These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32926843)

  • 1. The molecular mechanism involved in cardioprotection by the dietary flavonoid fisetin as an agonist of PPAR-γ in a murine model of myocardial infarction.
    Garg S; Khan SI; Malhotra RK; Sharma MK; Kumar M; Kaur P; Nag TC; RumaRay ; Bhatia J; Arya DS
    Arch Biochem Biophys; 2020 Nov; 694():108572. PubMed ID: 32926843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotective effects of azilsartan compared with that of telmisartan on an in vivo model of myocardial ischemia-reperfusion injury.
    Garg S; Khan SI; Malhotra RK; Sharma MK; Kumar M; Kaur P; Nag TC; Ray R; Bhatia J; Arya DS
    J Biochem Mol Toxicol; 2021 Jul; 35(7):e22785. PubMed ID: 33860986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chrysin rescues rat myocardium from ischemia-reperfusion injury via PPAR-γ/Nrf2 activation.
    Rani N; Arya DS
    Eur J Pharmacol; 2020 Sep; 883():173389. PubMed ID: 32707190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chrysin, a PPAR-γ agonist improves myocardial injury in diabetic rats through inhibiting AGE-RAGE mediated oxidative stress and inflammation.
    Rani N; Bharti S; Bhatia J; Nag TC; Ray R; Arya DS
    Chem Biol Interact; 2016 Apr; 250():59-67. PubMed ID: 26972669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fisetin Confers Cardioprotection against Myocardial Ischemia Reperfusion Injury by Suppressing Mitochondrial Oxidative Stress and Mitochondrial Dysfunction and Inhibiting Glycogen Synthase Kinase 3
    Shanmugam K; Ravindran S; Kurian GA; Rajesh M
    Oxid Med Cell Longev; 2018; 2018():9173436. PubMed ID: 29636855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice.
    Morrison A; Yan X; Tong C; Li J
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H895-902. PubMed ID: 21666107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
    Wayman NS; Hattori Y; McDonald MC; Mota-Filipe H; Cuzzocrea S; Pisano B; Chatterjee PK; Thiemermann C
    FASEB J; 2002 Jul; 16(9):1027-40. PubMed ID: 12087064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aleglitazar, a Balanced Dual PPARα and -γ Agonist, Protects the Heart Against Ischemia-Reperfusion Injury.
    Qian J; Chen H; Birnbaum Y; Nanhwan MK; Bajaj M; Ye Y
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):129-41. PubMed ID: 26861490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
    Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
    Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
    Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive effect of total flavones of Choerospondias axillaries on ischemia/reperfusion-induced myocardial infarction-related MAPK signaling pathway.
    Li C; He J; Gao Y; Xing Y; Hou J; Tian J
    Cardiovasc Toxicol; 2014 Jun; 14(2):145-52. PubMed ID: 24297260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of rats with hypolipidemic compound pirinixic acid protects their hearts against ischemic injury: are mitochondrial K(ATP) channels and reactive oxygen species involved?
    Nemčeková M; Čarnická S; Ferko M; Muráriková M; Ledvényiová V; Ravingerová T
    Physiol Res; 2013; 62(5):577-84. PubMed ID: 24020817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that the MEK/ERK but not the PI3K/Akt pathway is required for protection from myocardial ischemia-reperfusion injury by 3',4'-dihydroxyflavonol.
    Thomas CJ; Lim NR; Kedikaetswe A; Yeap YY; Woodman OL; Ng DC; May CN
    Eur J Pharmacol; 2015 Jul; 758():53-9. PubMed ID: 25820159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effect of acute treatment with rosiglitazone on rat myocardial ischemia/reperfusion injury by administration method.
    Abe M; Takiguchi Y; Ichimaru S; Kaji S; Tsuchiya K; Wada K
    Eur J Pharmacol; 2008 Jul; 589(1-3):215-9. PubMed ID: 18571644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.
    Bulhak AA; Jung C; Ostenson CG; Lundberg JO; Sjöquist PO; Pernow J
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H719-27. PubMed ID: 19151258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine protects rat heart from ischemia/reperfusion injury via activating JAK2/STAT3 signaling and attenuating endoplasmic reticulum stress.
    Zhao GL; Yu LM; Gao WL; Duan WX; Jiang B; Liu XD; Zhang B; Liu ZH; Zhai ME; Jin ZX; Yu SQ; Wang Y
    Acta Pharmacol Sin; 2016 Mar; 37(3):354-67. PubMed ID: 26806299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humanin exerts cardioprotection against cardiac ischemia/reperfusion injury through attenuation of mitochondrial dysfunction.
    Thummasorn S; Apaijai N; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Cardiovasc Ther; 2016 Dec; 34(6):404-414. PubMed ID: 27434747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of peroxisome proliferator-activated receptor-alpha protects the heart from ischemia/reperfusion injury.
    Yue TL; Bao W; Jucker BM; Gu JL; Romanic AM; Brown PJ; Cui J; Thudium DT; Boyce R; Burns-Kurtis CL; Mirabile RC; Aravindhan K; Ohlstein EH
    Circulation; 2003 Nov; 108(19):2393-9. PubMed ID: 14557369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butorphanol protects on myocardial ischemia/reperfusion injury in rats through MAPK signaling pathway.
    Wang H; Wang JL; Ren HW; He WF; Sun M
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10541-10548. PubMed ID: 31841210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fisetin attenuates isoproterenol-induced cardiac ischemic injury in vivo by suppressing RAGE/NF-κB mediated oxidative stress, apoptosis and inflammation.
    Garg S; Malhotra RK; Khan SI; Sarkar S; Susrutha PN; Singh V; Goyal S; Nag TC; Ray R; Bhatia J; Arya DS
    Phytomedicine; 2019 Mar; 56():147-155. PubMed ID: 30668335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.